サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1212610

単純ヘルペスウイルス感染症の世界市場 2023

Herpes Simplex Virus Infections
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 269 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
単純ヘルペスウイルス感染症の世界市場 2023
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 269 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

単純ヘルペスウイルス感染症の世界市場は、2030年に66億米ドルに達する

変化したCOVID-19後のビジネス環境において、2022年に48億米ドルと推定される単純ヘルペスウイルス感染症の世界市場は、2030年までに66億米ドルの改定規模に達し、2022年から2030年にかけて3.9%のCAGRで成長すると予測されます。

米国市場は13億米ドル、中国はCAGR6.6%で成長すると予測されています。

米国における単純ヘルペスウイルス感染症市場は、2022年に13億米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが6.6%で、2030年には14億米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ2.1％と3.3％の成長が予測されています。欧州では、ドイツがCAGR2.6%で成長すると予測されています。

調査対象企業の例

  • Admedus Limited
  • Agenus Inc.
  • Aicuris Anti-infective Cures Gmbh
  • Asahi Kasei Corporation
  • Chimerix Inc.
  • Clinigen Group Plc
  • Daewoong Pharmaceutical Co., Ltd.
  • F. Hoffmann-la Roche Ltd.
  • Glaxosmithkline Plc
  • Maruho Co. Ltd.
  • Merck
  • Mylan
  • Novartis
  • Sanofi Pasteur
  • Teva Pharmaceutical Industries Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6451

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Herpes Simplex Virus Infections Market to Reach $6.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Herpes Simplex Virus Infections estimated at US$4.8 Billion in the year 2022, is projected to reach a revised size of US$6.6 Billion by 2030, growing at a CAGR of 3.9% over the period 2022-2030.

The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 6.6% CAGR

The Herpes Simplex Virus Infections market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 3.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Select Competitors (Total 13 Featured):

  • Admedus Limited
  • Agenus Inc.
  • Aicuris Anti-infective Cures Gmbh
  • Asahi Kasei Corporation
  • Chimerix Inc.
  • Clinigen Group Plc
  • Daewoong Pharmaceutical Co., Ltd.
  • F. Hoffmann-la Roche Ltd.
  • Glaxosmithkline Plc
  • Maruho Co. Ltd.
  • Merck
  • Mylan
  • Novartis
  • Sanofi Pasteur
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Herpes Simplex Virus Infections - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Herpes Simplex Virus Infections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Herpes Simplex Virus Infections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Herpes Simplex Virus Infections Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • JAPAN
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • CHINA
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • EUROPE
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Herpes Simplex Virus Infections by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: Europe 18-Year Perspective for Herpes Simplex Virus Infections by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
  • FRANCE
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • GERMANY
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • UNITED KINGDOM
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • ASIA-PACIFIC
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Herpes Simplex Virus Infections by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 32: Asia-Pacific 18-Year Perspective for Herpes Simplex Virus Infections by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
  • AUSTRALIA
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • INDIA
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • LATIN AMERICA
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Herpes Simplex Virus Infections by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Latin America 18-Year Perspective for Herpes Simplex Virus Infections by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2023 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • MIDDLE EAST
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Herpes Simplex Virus Infections by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 54: Middle East 18-Year Perspective for Herpes Simplex Virus Infections by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2023 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • AFRICA
    • Herpes Simplex Virus Infections Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Herpes Simplex Virus Infections by Segment - Herpes Simplex Virus Infections Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR

IV. COMPETITION